1. Home
  2. KALV vs BV Comparison

KALV vs BV Comparison

Compare KALV & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.79

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

BV

BrightView Holdings Inc.

HOLD

Current Price

$12.47

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
BV
Founded
N/A
1939
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
KALV
BV
Price
$26.79
$12.47
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$32.60
$14.50
AVG Volume (30 Days)
5.4M
601.1K
Earning Date
07-09-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
$4.61
Revenue Next Year
$59.23
$1.90
P/E Ratio
N/A
N/A
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$11.06
52 Week High
$26.85
$17.11

Technical Indicators

Market Signals
Indicator
KALV
BV
Relative Strength Index (RSI) 74.93 50.76
Support Level $14.25 $11.34
Resistance Level $26.85 $13.29
Average True Range (ATR) 0.07 0.47
MACD -0.19 -0.03
Stochastic Oscillator 75.00 39.61

Price Performance

Historical Comparison
KALV
BV

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: